1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. UROGEN PHARMA LTD
UroGen Pharma Ltd XNAS: URGN
19.74 0.51 (2.65%)
386.9K
XNAS Volume

XNAS 22 Jan, 2026 1:33 PM (EST)

Watchlist

Portfolio

Alert

UroGen Pharma Ltd - URGN - stock price prediction, stock price target, analyst ratings from 8 analysts

UroGen Pharma Ltd has a share price target of US$ 35, revenue growth forecast of 25.4%, and profit growth estimate of -19.1% for FY25, based on top 8 analyst calls.